Doctor's Notes

Fine-Bubble Versus Conventional Shower in 23 Adults With Mild AD | Dr.

Fictional adult active-life illustration for Fine-Bubble Versus Conventional Shower in 23 Adults With Mild AD; faithful Dr. Arsy #003 jar; study did not test product

Evidence note: the lifestyle scene is a fictional AI-assisted illustration. It does not depict a study participant, clinician endorsement, diagnosis, or before/after result.

Why this active-life question matters

Twenty-three adults with mild AD completed two two-week shower periods separated by a two-week washout. The practical value is not a promise that one routine or product works for everyone. It is a closer look at how a specific exposure was measured, which comparison was made, and how much uncertainty remains.

Busy adults move between climate-controlled rooms, protective equipment, repeated washing, exercise, footwear and bathing. Those settings can change surface water, temperature, occlusion and measurement conditions. A reading such as transepidermal water loss is useful only when the anatomical site, acclimation, environment and timing are kept in view.

Study snapshot

Evidence element What the paper reports
Population and design Twenty-three adults with mild AD completed two two-week shower periods separated by a two-week washout.
Comparator Conventional shower
Timepoint/exposure Fine-bubble shower
Numerical result Day 0-14 EASI change: 0.62 vs 0.05, P=0.35; TEWL and hydration changes also showed no between-group differences.
Important limitation Small crossover, missing second-period baselines and standardized petrolatum use limit inference; no superiority was shown.
Funding JUTAK20684/MTG Co., Ltd.
Conflicts Hiroshi Kato, Risa Tamagawa‐Mineoka, Eiji Nakatani, and Kenichi Yoshimura received research funding from MTG Co. Ltd. Hiroshi Kato received technical consulting fees from MTG Co. Ltd. Ako Kurachi and Soshi Takeda are employees of MTG Co. Ltd. MTG Co. Ltd. also provided the test equipment (a fine bubble shower head) and body soap. Care was taken to avoid bias when interpreting the content and results of the study. Hiroshi Kato serves as an advertising ambassador for Product Curel (Kao Corp.) and receives financial compensation.

What the investigators actually did

Atopic dermatitis (AD) involves chronic eczema resulting from barrier dysfunction. Fine bubble (FB) technology generates microbubbles (< 100 μm) and ultrafine bubbles (< 1 μm) for surfactant-sparing cleansing. We assessed the short-term safety of an FB shower in AD. In this double-blind, randomized, crossover study, adults with mild AD completed two 2-week periods separated by a 2-week washout in sequence. Bathing instructions and petrolatum moisturizer use were standardized and enforced. The Eczema Area and Severity Index (EASI) was scored using whole-body photographs by a blinded team. Transepidermal water loss (TEWL) and stratum corneum hydration were measured on Days 0, 14, and 28. Because baselines were unavailable for the second 2-week period, the primary analysis compared Day 0-14 changes between groups using baseline-adjusted analysis of covariance; Day 0-28 changes were also explored. The primary outcomes were EASI changes; TEWL and hydration were the secondary outcomes. Groups used a conventional shower (control) first and then FB shower second or vice versa (once each). Twenty-three participants were analyzed (mean age 40.9 ± 8 years; 83% male). Day 0-14 EASI changes did not differ between FB and control (0.62 ± 2.21 vs. 0.05 ± 0.68; F = 0.93, p = 0.35). EASI changes to Day 28 were nonsignificant (0.02 ± 1.65 vs. -0.03 ± 1.02; p = 0.90). TEWL changes for Days 0-14 (0.31 ± 4.75 vs. 1.09 ± 6.21 g/m2/h) and to Day 28 (5.49 ± 14.43 vs. -0.27 ± 5.28 g/m2/h) showed no between-group differences. Hydration changes were similar for Days 0-14 (5.53 ± 13.23 vs. 6.14 ± 7.96 AU) and to Day 28 (18.41 ± 10.33 vs. 21.09 ± 11.07 AU). No serious adverse events or discontinuations for worsening symptoms occurred. Under standardized, low-irritant conditions, the FB shower was well-tolerated by adults with mild AD and did not worsen severity or barrier indices over 4 weeks. However, the superiority of FB to a conventional shower was not demonstrated.

How to read the result without overreaching

Day 0-14 EASI change: 0.62 vs 0.05, P=0.35; TEWL and hydration changes also showed no between-group differences. This finding belongs to the cited design, population and timepoint. It should not be converted into a diagnosis, a universal rule, or proof that a cosmetic moisturizer prevents or treats disease.

Small crossover, missing second-period baselines and standardized petrolatum use limit inference; no superiority was shown. The result may still help readers notice which parts of daily life deserve attention: exposure duration, recovery time, anatomical site, product or material formulation, and whether the comparison was randomized, observational or within-person.

Practical, claim-safe routine thinking

  • Use the gentlest routine that fits the task and workplace rules.
  • After washing, dry carefully and pay attention to repeated friction, heat and occlusion.
  • For persistent cracking, rash, swelling, pain, drainage or infection concerns, seek qualified medical care.
  • Do not assume that results from a study formulation, device, sock, cleanser, glove or shower system apply to a different product.

View Dr. Arsy #003 Moisturizer

Continue reading

Primary and authoritative sources

PubMed indexing identifies a bibliographic record; it is not NIH endorsement.

← Back to Doctor's Notes